With a market cap of $121,1 billion, Gilead Sciences, Inc. (GILD) is a leading biopharmaceutical company specializing in the discovery, development, and commercialization of innovative medicines.
Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly effective medicine. However, Ben Hargreaves finds that the company’s ...
With the FDA approval of Gilead's seladelpar, there have now been two in a matter of weeks. The US agency has cleared seladelpar under the Livdelzi brand name as a second-line therapy for PBC in ...
Follow in the footsteps of your favourite on-screen characters on a ‘set-jetting’ adventure — be it from the lush terraces of ...
A Standish woman died Saturday night after she crashed a car into a tree on Brighton Avenue near Highland Street in Portland. Portland police said Katy Jayne Billie, 42, was driving when she left the ...
After hours: 7:57:19 pm GMT-5 ...
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...
Each country’s power reflects its prowess in various aspects, including economic and political influence, strength in international alliances, and military capability. The rankings of the top 10 ...
Morning sunlight falls on the facade of the New York Stock Exchange (NYSE) building in Manhattan in New York City, New York, U.S., January 28, 2021. REUTERS/Mike Segar/File Photo The S&P 500 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback